| Product Code: ETC4759216 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Vaccines Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Vaccines Market - Industry Life Cycle |
3.4 Netherlands Vaccines Market - Porter's Five Forces |
3.5 Netherlands Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Netherlands Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Netherlands Vaccines Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Netherlands Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Netherlands Vaccines Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
4 Netherlands Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives and funding for vaccination programs in the Netherlands |
4.2.2 Growing awareness about the importance of vaccination in preventing diseases |
4.2.3 Technological advancements in vaccine development and production |
4.3 Market Restraints |
4.3.1 Vaccine hesitancy among certain segments of the population |
4.3.2 Regulatory challenges and approval processes for new vaccines |
4.3.3 Competition from alternative medicine practices |
5 Netherlands Vaccines Market Trends |
6 Netherlands Vaccines Market Segmentations |
6.1 Netherlands Vaccines Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Vaccines Market Revenues & Volume, By Conjugate vaccines, 2021-2031F |
6.1.3 Netherlands Vaccines Market Revenues & Volume, By Inactivated and subunit vaccines, 2021-2031F |
6.1.4 Netherlands Vaccines Market Revenues & Volume, By Live attenuated vaccines, 2021-2031F |
6.1.5 Netherlands Vaccines Market Revenues & Volume, By Recombinant vaccines, 2021-2031F |
6.1.6 Netherlands Vaccines Market Revenues & Volume, By Toxoid vaccines, 2021-2031F |
6.2 Netherlands Vaccines Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Vaccines Market Revenues & Volume, By Monovalent vaccines, 2021-2031F |
6.2.3 Netherlands Vaccines Market Revenues & Volume, By Multivalent vaccines, 2021-2031F |
6.3 Netherlands Vaccines Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Vaccines Market Revenues & Volume, By Pneumococcal disease, 2021-2031F |
6.3.3 Netherlands Vaccines Market Revenues & Volume, By DTP, 2021-2031F |
6.3.4 Netherlands Vaccines Market Revenues & Volume, By Influenza, 2021-2031F |
6.3.5 Netherlands Vaccines Market Revenues & Volume, By HPV, 2021-2031F |
6.3.6 Netherlands Vaccines Market Revenues & Volume, By Meningococcal disease, 2021-2031F |
6.3.7 Netherlands Vaccines Market Revenues & Volume, By Polio, 2021-2031F |
6.3.8 Netherlands Vaccines Market Revenues & Volume, By Other disease indications, 2021-2031F |
6.3.9 Netherlands Vaccines Market Revenues & Volume, By Other disease indications, 2021-2031F |
6.4 Netherlands Vaccines Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Vaccines Market Revenues & Volume, By Intramuscular and subcutaneous administration, 2021-2031F |
6.4.3 Netherlands Vaccines Market Revenues & Volume, By Oral administration, 2021-2031F |
6.4.4 Netherlands Vaccines Market Revenues & Volume, By Other routes of administration, 2021-2031F |
6.5 Netherlands Vaccines Market, By Patient Type |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Vaccines Market Revenues & Volume, By Pediatric patients, 2021-2031F |
6.5.3 Netherlands Vaccines Market Revenues & Volume, By Adult patients, 2021-2031F |
7 Netherlands Vaccines Market Import-Export Trade Statistics |
7.1 Netherlands Vaccines Market Export to Major Countries |
7.2 Netherlands Vaccines Market Imports from Major Countries |
8 Netherlands Vaccines Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates across different age groups |
8.2 Number of new vaccines introduced or approved for use in the Netherlands |
8.3 Investments in research and development for new vaccine technologies |
9 Netherlands Vaccines Market - Opportunity Assessment |
9.1 Netherlands Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Netherlands Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Netherlands Vaccines Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Netherlands Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Netherlands Vaccines Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
10 Netherlands Vaccines Market - Competitive Landscape |
10.1 Netherlands Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here